Advancements in TB Diagnosis and Treatment

Highlights on Tuberculosis Diagnosis and Innovations in India

World Health Organization (WHO) Recommendations:

• Recommended use of near point-of-care (NPOC) molecular tests for TB diagnosis.
• Endorsed use of tongue swab samples and sputum pooling strategies to enhance testing efficiencies.

Technological Advancements:

• Significant increase in the use of portable chest X-ray (CXR) combined with artificial intelligence (AI) for TB screening.
• The National TB Elimination Programme (NTEP) in India has deployed hundreds of portable CXR machines as part of the Pradhan Mantri TB Mukt Bharat Abhiyaan.

Access and Diagnostics:

• Improved accessibility to X-ray services by mobile units equipped with AI, allowing community-based screening.
• Pivot from sputum smear microscopy to more effective molecular testing (e.g., CBNAAT, indigenous Truenat), a significant shift for TB diagnosis over the last decade.

Current Challenges and Needs:

• Unequal access to molecular testing necessitates strengthening of sputum collection and transportation, especially for vulnerable populations.
• Need to streamline drug resistance testing to ensure timely initiation of correct treatment regimens.

New Diagnostic Tools:

• The advent of nPOC-NAAT allows testing at primary-care level with minimal infrastructure.
• Identification of non-sputum sample testing methods, particularly for children who struggle to provide sputum samples.

Research and Innovation Areas:

1. Development of cost-effective biomarkers for high-risk disease progression prediction.
2. Expanding access to faster and less invasive diagnostic tools (e.g., saliva tests).
3. Exploring diagnostics for pediatric TB and extra-pulmonary TB (EP-TB), which constitutes a significant burden.
4. Implementation of AI-enabled portable ultrasound devices in conjunction with new molecular testing.

Community Engagement:

• Importance of community-led programs to drive demand for new diagnostic tools, addressing hesitancy towards screening and preventive therapy.

Economic Impact:

• Early diagnosis linked to improved treatment outcomes and reduced long-term health complications.
• Reduced treatment-related out-of-pocket expenditures for affected families.

Strategic Recommendations:

• Investment in diagnostic landscape improvement as a critical return on investment for public health.
• Formation of clear diagnostic algorithms combining AI-enabled CXR with molecular tests for comprehensive detection.

Constitutional and Legislative Framework:

• The commitment towards TB elimination aligns with Article 21 (Right to Life) of the Indian Constitution, ensuring health as a fundamental right.
• Continuous evaluation of health innovations through rigorous assessments by bodies like the Indian Council of Medical Research (ICMR) underscores a structured approach to public health policy.

Conclusion:

Enhancing diagnostic pathways for TB through technological innovations, optimizing resource allocation, and ensuring community involvement can significantly accelerate India’s progress towards TB elimination.